Article
Public (all visitors)
FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease | Berkeley News
Berkeley News
2021
Resources from Berkeley News
UC scientists and physicians hope to permanently cure patients of sickle cell disease by using CRISPR-Cas9 to replace a defective gene with the normal version
Comments
Keep exploring
Related resources
More to explore from shared collections and topics.
Contribute to BackpackerU Resources
Found something worth adding?
Sign in to suggest resources and start organizing your own travel-learning library.
No comments yet.